Deals and cases

Deals and cases

Browse our deals and cases

Filter information in our deals and cases database

  • 14.05.2019

    Advising TBD-Biodiscovery on involving a Dutch investor from SEAL Investments B.V.

    TGS Baltic's team, led by partner Leonid Tolstov, advised the leading Estonian biotechnology company TBD-Biodiscovery and its sole shareholder on involving a Dutch investor from SEAL Investments B.V., who acquired 30% of the company's shares and will be investing a total of EUR 4.5 million in the company in the next few years. This is one of the largest foreign investments in an Estonian biotechnology company.

    More
  • 01.01.2019

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline

    TGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline, a science-led global healthcare company. We advised Client on a Pan-Baltic level in a project related to development of internal public procurement policies, ebracing the best practices for various corporate and public procurement issues, including but not limited to protection of confidencial information, fair competition and proper participation in tender produres and etc. These policies reflected boath national regulation and case law, as well as the case law of the European Court of Justice and provisions of the EU public procurement directives.

  • 04.03.2018

    TGS Baltic advised VIKONDA Group, one of the biggest business groups in Lithuania

    TGS Baltic advised VIKONDA Group (VIKONDA Concern), one of the biggest business groups in Lithuania with significant interests in food, trade, crop, media industries, construction, and other services, with a consolidated annual turnover of approximately EUR 145 million, on a complex holding restructuring.

     

    More
  • 11.09.2017

    TGS Baltic assisted BENU Aptieka Latvija SIA with acquisition of 100% of share of SIA Cēsu Vecpilsētas Aptieka

    Andra Rubene, Attorney at Law, Partner, and Rūdolfs Vilsons, Associate at TGS Baltic assisted BENU Aptieka Latvija SIA, one of the leading retail of medicines chains in the Baltics, with acquisition of 100% shares SIA Cēsu Vecpilsētas Aptieka, a pharmacy in Cēsis, Latvia from a number of private persons, thereby expanding Benu network of more than 66 pharmacies in Latvia.

    More
  • 01.01.2017

    Eugenija Sutkienė awarded as Market Maker for Lithuania

    On 1 June 2017, at a special awards ceremony at the Intercontinental Hotel in Warsaw, Eugenija Sutkienė was named the Market Maker for Lithuania, which is a special lifetime achievement award given to a senior lawyer identified by peers as having played the most influential and significant role in creating the country’s modern legal market

    More
  • 29.09.2016

    Advising Viru Haigla on the acquisition of Karell Kiirabi

    The firm’s M&A team led by associate partner Sander Kärson advised the strategic investor Viru Haigla on the acquisition of Karell Kiirabi from U.S. Invest.

    More
  • 05.02.2015

    Represented the largest orthopaedic technical products company in a dispute with the National Health Insurance Fund

    TGS Baltic successfully represented an orthopaedic technical products manufacturer in Lithuania in a dispute with the National Health Insurance Fund with regard to the right to issue orthopaedic technical products to the patients and receive compensation from state funds.

    More
  • 28.01.2015

    Represented the client in a legal dispute against the Republic of Lithuania

    TGS Baltic successfully represented one of the largest companies in the sector of orthopaedic technical products in a legal dispute against the Republic of Lithuania regarding the refusal to compensate the client for orthopaedic technical products issued by the company to patients (case re State liability).

    More
  • 26.11.2014

    TGS Baltic receives continuing high rankings from IFLR1000 in Baltic countries

    IFLR1000 (International Financial Law Review) is the guide of world’s leading financial law firms. The guide analysis and ranks more than 120 jurisdictions in the world.

    More
  • 01.01.2014

    Northway Group Unique and Long-Term Legal Solutions

    TGS Baltic is the main legal advisor of Northway Group, which consists of 11 companies dealing in pharmacy and biotechnologies, provision of health care services and investments.

    More
  • 01.01.2014

    Novo Nordisk Optimization of Medical-Product Supply Chain in Baltic Region

    TGS Baltic advised Novo Nordisk on the reorganization of its supply chain for medicinal products in the Baltic States, and prepared the relevant documentation.

    More
  • 01.01.2014

    Operations of a manufacturer and distributor of medicinal products in Latvia

    TGS Baltic provides day-to-day legal assistance to a manufacturer and distributor of medicinal products in Latvia, including regarding discounts for medicinal products offered to hospitals through public tenders and donations of medicinal products to hospitals, clinical trials, safety reporting, suspected unexpected serious adverse reactions, scientific services, M&A and corporate, employment, data protection, bribery and competition law issues.

  • 01.01.2014

    Manufacturers of medicinal products require including of innovative medicinal products in the list of reimbursable medicinal products

    TGS Baltic drafted an agreement of manufacturers of medicinal products with the National Health Service on including of innovative medicinal products in the list of reimbursable medicinal products pursuant to the requirements set by the Cabinet regulations No.899 “Procedures for the Reimbursement of Expenditures for the Acquisition of Medicinal Products and Medicinal Devices Intended for Out-patient Medical Treatment”.

  • 01.11.2013

    Bond Issue by Valeant Pharmaneuticals

    TGS Baltic advised Valeant Pharmaceuticals International, Inc. on all legal matters related to the collaterals and securities in Lithuania that were created as per financing from Goldman Sachs Bank USA for the acquisition of Bausch & Lomb Holdings Incorporated. Valeant Pharmaceuticals owns and operates a significant production facility in Lithuania.

  • 07.05.2013

    Chambers Europe 2013 top ranks the firm and its 18 “Leading Lawyers”

    Chambers Europe, a major European legal directory, gave TGS Baltic the highest rankings in corporate/commercial, employment, competition/antitrust and energy practices in its 2013 edition.

    More
  • 02.04.2013

    Chambers Global 2013 ranks TGS Baltic among leading law firms

    Law firm TGS Baltic and its lawyers are ranked in top tiers in Chambers Global’s newest, 2013 edition. The edition analyzes corporate/commercial and dispute resolution practice areas in the Baltics.

    More
  • 01.01.2013

    Potential Violations of EU Law by Proposed Amendments

    TGS Baltic represented a number of associations of healthcare institutions in the successful request for the European Commission to open a case regarding potential violations of EU law in proposed amendments to Lithuania's Law on Health Insurance.

  • 01.01.2013

    Tax Advisory Services Regarding Establishment of a Holding

    TGS Baltic counselled Tamro, the largest pharmaceutical distributor in the Baltics, on tax issues related to best jurisdiction for establishing a holding in the Baltic States.

    More
  • 01.01.2013

    Northway Medical Centres Tax Advisory Services

    TGS Baltic provided tax advisory services to Northway Medical Centres, one of the largest private medical centres in Lithuania providing comprehensive medical, day surgery and rehabilitation services, regarding invoicing, VAT, income tax and other tax law issues.

  • 01.01.2013

    Sanitas Squeeze-Out Procedure

    TGS Baltic advised and provided full transaction servicesto Valeant Pharmaceuticals International Inc., one of the largest Canadian pharmaceutical companies, in the squeeze-out of Sanitas minority shareholders and successful acquisition of 100% of Sanitas shares. This enabled Valeant to exercise sole control over Sanitas, delist it from the Nasdaq OMX Vilnius exchange and relieve Sanitas of extensive reporting and accountability duties associated with public listing of shares.